Published in Oncogene on March 12, 2012
SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell (2014) 1.73
The emerging and diverse roles of sirtuins in cancer: a clinical perspective. Onco Targets Ther (2013) 1.57
ATRA-induced cellular differentiation and CD38 expression inhibits acquisition of BCR-ABL mutations for CML acquired resistance. PLoS Genet (2014) 1.48
Sorting out functions of sirtuins in cancer. Oncogene (2013) 1.47
Janus-faced role of SIRT1 in tumorigenesis. Ann N Y Acad Sci (2012) 1.43
Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer. Oncotarget (2012) 1.08
Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance. J Exp Med (2013) 1.06
The multifaceted functions of sirtuins in cancer. Nat Rev Cancer (2015) 1.04
Sirtuin inhibitors as anticancer agents. Future Med Chem (2014) 0.98
Emerging Roles of SIRT1 in Cancer Drug Resistance. Genes Cancer (2013) 0.97
Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer. Oncotarget (2013) 0.95
KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair. PLoS One (2015) 0.94
Inhibition of the NAD-dependent protein deacetylase SIRT2 induces granulocytic differentiation in human leukemia cells. PLoS One (2013) 0.92
Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells. Curr Opin Hematol (2015) 0.87
A divergent role of the SIRT1-TopBP1 axis in regulating metabolic checkpoint and DNA damage checkpoint. Mol Cell (2014) 0.85
Roles of SIRT1 in leukemogenesis. Curr Opin Hematol (2013) 0.83
Expression of nicotinamide phosphoribosyltransferase-influenced genes predicts recurrence-free survival in lung and breast cancers. Sci Rep (2014) 0.82
Sirtuins in hematological aging and malignancy. Crit Rev Oncog (2013) 0.82
Leukemia stem cells: the root of chronic myeloid leukemia. Protein Cell (2015) 0.81
[New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein]. Yakugaku Zasshi (2011) 0.80
Genetic variation in SIRT1 affects susceptibility of lung squamous cell carcinomas in former uranium miners from the Colorado plateau. Carcinogenesis (2013) 0.80
Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells. Nutrients (2016) 0.79
Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition. Exp Hematol (2016) 0.79
SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells. Oncotarget (2016) 0.78
Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy. Oncotarget (2017) 0.77
CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1. Stem Cells (2015) 0.76
Tenovin-6 impairs autophagy by inhibiting autophagic flux. Cell Death Dis (2017) 0.76
Sirtuins, tissue maintenance, and tumorigenesis. Genes Cancer (2013) 0.76
The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer. Mol Cancer Ther (2016) 0.75
SIRT1 and LSD1 competitively regulate KU70 functions in DNA repair and mutation acquisition in cancer cells. Oncotarget (2016) 0.75
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med (2006) 22.86
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature (2000) 20.54
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science (2001) 20.30
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science (2004) 17.38
hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97
Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 15.05
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med (2006) 13.54
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell (2002) 13.03
Overriding imatinib resistance with a novel ABL kinase inhibitor. Science (2004) 11.83
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science (2004) 11.39
DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet (2001) 10.77
Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer (2006) 9.15
Mammalian SIRT1 represses forkhead transcription factors. Cell (2004) 8.89
Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. N Engl J Med (2006) 8.26
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell (2005) 7.99
Dynamics of chronic myeloid leukaemia. Nature (2005) 6.63
SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell (2008) 5.76
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell (2008) 5.11
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell (2005) 5.04
Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet (2008) 4.71
Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A (2004) 3.93
Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell (2004) 3.73
Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer (2007) 3.63
Targeting tyrosine kinases in cancer: the second wave. Science (2006) 3.52
Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat Struct Mol Biol (2009) 2.76
SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature (2007) 2.76
Sirtuins in aging and disease. Cold Spring Harb Symp Quant Biol (2007) 2.66
Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat Struct Mol Biol (2009) 2.64
Coupled homologous and nonhomologous repair of a double-strand break preserves genomic integrity in mammalian cells. Mol Cell Biol (2000) 2.57
Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet (2008) 2.55
DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc Natl Acad Sci U S A (2004) 2.51
Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest (2010) 2.44
SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell (2007) 2.42
Assaying double-strand break repair pathway choice in mammalian cells using a targeted endonuclease or the RAG recombinase. Methods Enzymol (2006) 2.21
BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell (2001) 2.09
Multiple functions of MRN in end-joining pathways during isotype class switching. Nat Struct Mol Biol (2009) 2.05
Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev (2003) 2.02
BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood (2004) 1.95
Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell (2010) 1.92
NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene (2010) 1.58
Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature (1997) 1.54
Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. Blood (2011) 1.52
Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition? J Biol Chem (2008) 1.46
Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia. Leukemia (2010) 1.32
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis? Mol Cancer Res (2006) 1.31
Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer. Cancer Res (2002) 1.30
Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci U S A (2010) 1.30
Binding of Ku and c-Abl at the kinase homology region of DNA-dependent protein kinase catalytic subunit. J Biol Chem (1997) 1.29
Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection. Mol Cell (2011) 1.29
Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation. J Biol Chem (2008) 1.27
BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells. DNA Repair (Amst) (2005) 1.23
Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells. Cancer Res (2003) 1.20
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells. Clin Cancer Res (2006) 1.12
BCR-ABL gene expression is required for its mutations in a novel KCL-22 cell culture model for acquired resistance of chronic myelogenous leukemia. J Biol Chem (2009) 1.11
Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins. Cancer Res (2003) 1.07
HIC1 hypermethylation is a late event in hematopoietic neoplasms. Cancer Res (1997) 1.04
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69
Observations on the brains of demented old people. J Neurol Sci (1970) 6.99
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol (1995) 6.33
CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry (1986) 6.14
Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell (2001) 5.19
Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 4.45
Observations on the brains of non-demented old people. J Neurol Sci (1969) 4.06
Do general practitioners miss dementia in elderly patients? BMJ (1988) 3.95
Fluorescence reaction for amino acids. Anal Chem (1971) 3.55
Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India (2007) 3.52
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest (1995) 3.52
Brassinosteroid-insensitive dwarf mutants of Arabidopsis accumulate brassinosteroids. Plant Physiol (1999) 3.37
A single amino acid change in the cytoplasmic domain allows the influenza virus hemagglutinin to be endocytosed through coated pits. Cell (1988) 3.26
Mental illness and hospital usage in the elderly: a random sample followed up. Compr Psychiatry (1970) 3.25
Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J (1999) 3.18
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology (1992) 3.17
Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J (2001) 3.08
Special problems of the aged and the organization of hospital services. Br Med J (1966) 3.01
Can visceral leishmaniasis be eliminated from Asia? J Vector Borne Dis (2008) 2.84
Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet (1995) 2.81
Pharmacokinetics of sevoflurane uptake into the brain and body. Anaesthesia (2003) 2.78
Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J Biol Chem (1999) 2.67
Production of listeriolysin by beta-hemolytic strains of Listeria monocytogenes. Infect Immun (1986) 2.66
Isolation and identification of two hemolytic forms of streptolysin-O. Infect Immun (1984) 2.57
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Double-strand breaks and tumorigenesis. Trends Cell Biol (2001) 2.53
A study of the localisation of a protein antigen in the chicken spleen and its relation to the formation of germinal centres. J Med Microbiol (1970) 2.51
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48
The 1.7 A crystal structure of the regulator of chromosome condensation (RCC1) reveals a seven-bladed propeller. Nature (1998) 2.42
Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40
Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med (2001) 2.34
Mechanisms for soil moisture effects on activity of nitrifying bacteria. Appl Environ Microbiol (1995) 2.34
The Arabidopsis dwarf1 mutant is defective in the conversion of 24-methylenecholesterol to campesterol in brassinosteroid biosynthesis. Plant Physiol (1999) 2.26
Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects. Nature (1966) 2.23
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A (1996) 2.11
Expression of enzymatically active reverse transcriptase in Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.11
Elimination of neglected tropical diseases in the South-East Asia Region of the World Health Organization. Bull World Health Organ (2010) 2.07
Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol (1985) 2.06
Solid cancers after bone marrow transplantation. J Clin Oncol (2001) 1.99
Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiol Aging (1990) 1.99
Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol (1998) 1.96
Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol (1998) 1.92
Selenium, molybdenum, and vanadium in human blood. Arch Environ Health (1968) 1.89
Management and outcome of pyogenic vertebral osteomyelitis. Clin Orthop Relat Res (1978) 1.88
Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science (2001) 1.84
Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes. Bull World Health Organ (1998) 1.82
A high throughput screen to identify secreted and transmembrane proteins involved in Drosophila embryogenesis. Proc Natl Acad Sci U S A (1998) 1.79
Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78
DNA intermediates and telomere addition during genome reorganization in Euplotes crassus. Cell (1985) 1.77
Column chromatography of amino acids with fluorescence detection. J Chromatogr (1973) 1.76
Renal abnormalities in schoolchildren. Pediatrics (1989) 1.74
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood (2000) 1.74
Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Aging (1983) 1.71
A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China. Clin Genet (2007) 1.66
Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. Am J Pathol (1990) 1.64
Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology (1982) 1.64
Heat and water loss from the airways and exercise-induced asthma. Respiration (1977) 1.63
Disequilibrium in control of proteolysis as a cause of pre-eclampsia. Lancet (1978) 1.63
Diethylene glycol poisoning in Gurgaon, India, 1998. Bull World Health Organ (2003) 1.62
Community studies on prevalence of HBsAg in two urban populations of southern India. Indian Pediatr (2000) 1.62
A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain (1982) 1.62
Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol (1997) 1.62
Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol Cell Biol (1994) 1.61
Use of statistical techniques in classification of affective disorders. Proc R Soc Med (1970) 1.61
Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology (1987) 1.61
Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial. Neurol India (2012) 1.61
A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology (1990) 1.60
Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem (1999) 1.59
NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene (2010) 1.58
Rapid estimation of bacterial antibiotic susceptibility with flow cytometry. J Microsc (1994) 1.58
House dust mite extract downregulates C/EBPα in asthmatic bronchial smooth muscle cells. Eur Respir J (2010) 1.57
The ability of membrane potential dyes and calcafluor white to distinguish between viable and non-viable bacteria. J Appl Bacteriol (1995) 1.57
Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem (1996) 1.56
Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells. Circulation (1999) 1.55
Mesquite pollen--an aeroallergen in asthma and allergic rhinitis. J Allergy Clin Immunol (1977) 1.55
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy. Leukemia (2010) 1.54
Malignant rhabdoid tumour of colon. Histopathology (1994) 1.54
The imprint of the extragalactic background light in the gamma-ray spectra of blazars. Science (2012) 1.53
Mesohepatectomy for centrally located liver tumours. Br J Surg (2013) 1.53
The dynamic air bubble trap reduces cerebral microembolism during cardiopulmonary bypass. J Thorac Cardiovasc Surg (2003) 1.52
Laparoscopic fusion of the lumbar spine: minimally invasive spine surgery. A prospective multicenter study evaluating open and laparoscopic lumbar fusion. Spine (Phila Pa 1976) (1999) 1.51
Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) J Am Coll Cardiol (1992) 1.50
Four-year follow-up results of lumbar spine arthrodesis using the Bagby and Kuslich lumbar fusion cage. Spine (Phila Pa 1976) (2000) 1.50
Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia (2008) 1.49
Large scale synchronous mating and the study of macronuclear development in Euplotes crassus. J Cell Biol (1985) 1.49
Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia (2005) 1.49
Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. AJNR Am J Neuroradiol (2011) 1.49
Hearing loss in paranoid and affective psychoses of the elderly. Lancet (1974) 1.48
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Does early intervention reduce the number of elderly people with dementia admitted to institutions for long term care? BMJ (1991) 1.46
The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand (1989) 1.45
Intense high-energy proton beams from Petawatt-laser irradiation of solids. Phys Rev Lett (2000) 1.45
Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesion. Am J Respir Cell Mol Biol (1992) 1.43
Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol (2001) 1.42
Elasticity and adhesion force mapping reveals real-time clustering of growth factor receptors and associated changes in local cellular rheological properties. Biophys J (2004) 1.42
Contrast-echocardiography: confirmation of patency of laser channels after transmyocardial laser revascularization. Eur J Echocardiogr (2002) 1.40
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells. Blood (1998) 1.39